Abstract
The pathogenicity of Mycobacterium tuberculosis depends upon its ability to catabolize host cholesterol. Upregulation of the methylcitrate cycle (MCC) is required to assimilate and detoxify propionyl-CoA, a cholesterol degradation product. The transcription of key genes prpC and prpD in MCC is activated by MtPrpR, a member of a family of prokaryotic transcription factors whose structures and modes of action have not been clearly defined. We show that MtPrpR has a novel overall structure and directly binds to CoA or short-chain acyl-CoA derivatives to form a homotetramer that covers the binding cavity and locks CoA tightly inside the protein. The regulation of this process involves a [4Fe4S] cluster located close to the CoA-binding cavity on a neighboring chain. Mutations in the [4Fe4S] cluster binding residues rendered MtPrpR incapable of regulating MCC gene transcription. The structure of MtPrpR without the [4Fe4S] cluster-binding region shows a conformational change that prohibits CoA binding. The stability of this cluster means it is unlikely a redox sensor but may function by sensing ambient iron levels. These results provide mechanistic insights into this family of critical transcription factors who share similar structures and regulate gene transcription using a combination of acyl-CoAs and [4Fe4S] cluster.
Highlights
Mycobacterium tuberculosis (Mtb) caused an estimate of 1.6 million deaths in 2017 alone, and has developed resistance to many commonly used antibiotics [1]
Our study showed that MtPrpR directly binds to CoA or CoA derivatives, and that the binding is under the control of an iron-sulfur cluster which is located at the C-terminal region of the protein in close proximity to the CoA-binding cavity of a neighboring chain
Based on the crystal structures and our model, it appears that MtPrpR can adopt inactive and active conformations by binding to different CoA derivatives
Summary
Mycobacterium tuberculosis (Mtb) caused an estimate of 1.6 million deaths in 2017 alone, and has developed resistance to many commonly used antibiotics [1]. Part of Mtb’s effectiveness as a pathogen is that it can use fatty acids and cholesterol as primary nutrient sources during infection [2–4]. The degradation of both odd-chain fatty acids and cholesterol produces propionyl coenzyme A (propionylCoA) [5–9] which must be further metabolized as accumulation of propionyl-CoA leads to the toxicity to the bacilli [10,11]. The key enzymes of the MCC are typically clustered in the propionate metabolic operon (prp operon), which includes methylcitrate synthase (MCS, named PrpC), methylcitrate dehydratase (MCD, named PrpD) and methylisocitrate lyase (MCL, named PrpB) [10,12]. The prp operon of Mtb only contains two genes prpC (rv1131) and prpD (rv1130). Certain strains of Mtb, including the clinical strain CDC1551, contain a second copy of Icl (Icl2), which has minimal MCL activity [12]
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have